WallStreetZenWallStreetZen

NASDAQ: MRSN
Mersana Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Mersana Therapeutics earnings were -$69.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest MRSN earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$14.1M, up 22.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MRSN reported annual earnings of -$69.2M, with -59.7% growth. The next MRSN earnings date is May 7, 2025.

MRSN earnings history

Current Revenue
$40.5M
Current Earnings
-$69.2M
Current Profit Margin
-170.9%

MRSN Return on Equity

Current Company
-990.2%
Current Industry
-2%
Current Market
34.1%
MRSN's Return on Equity (-990.2%)... subscribe to Premium to read more.
High Return on Equity Performance

MRSN undefined

Current Company
-40%
Current Industry
-0.4%
MRSN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MRSN announces earnings.

MRSN undefined

Current Company
-78.95%
Current Industry
5.9%
MRSN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MRSN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MRSN-$60.16M-$69.19MN/A-$0.56
OKYO-$10.35M-$10.69MN/A-$0.38
CYCC-$11.99M-$11.21MN/A-$2.09
KRON-$84.36M-$86.08MN/A-$1.43
ACET-$107.45M-$117.12MN/A-$1.33
View Top Biotech Stocks

MRSN earnings dates

Next earnings date
May 7, 2025

Mersana Therapeutics Earnings Reports & History FAQ

What were Mersana Therapeutics's earnings last quarter?

On MRSN's earnings call on Invalid Date, Mersana Therapeutics (NASDAQ: MRSN) reported Q4 2024 earnings per share (EPS) of -$0.11, up 26.67% year over year. Total MRSN earnings for the quarter were -$14.12 million. In the same quarter last year, Mersana Therapeutics's earnings per share (EPS) was -$0.15.

If you're new to stock investing, here's how to buy Mersana Therapeutics stock.

When does Mersana Therapeutics report earnings?

The next MRSN earnings date is Invalid Date. Add MRSN to your watchlist to be reminded of Mersana Therapeutics's next earnings date.

Is Mersana Therapeutics profitable or losing money?

As of the last Mersana Therapeutics earnings report, Mersana Therapeutics is currently losing money. Mersana Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$69.19 million, a 59.69% decrease year over year.

What was MRSN's earnings growth in the past year?

As of Mersana Therapeutics's earnings date in Invalid Date, Mersana Therapeutics's earnings has grown year over year. MRSN earnings in the past year totalled -$69.19 million.

What are Mersana Therapeutics's earnings expectations?

The current EPS estimate for Mersana Therapeutics's earnings report in Invalid Date is -$0.18.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.